BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)

China · Delayed Price · Currency is CNY

49.52

+3.03 (6.52%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Income from sale of Products			1.02B	877.52M	927.80M	670.46M	386.39M
Income from sale of Products Growth			16.63%	-5.42%	38.38%	73.52%	10.90%
Income from Technology			75.80M	84.39M	67.78M	47.01M	79.15M
Income from Technology Growth			-10.17%	24.50%	44.17%	-40.60%	147.13%
Equity Share Income			61.90M	51.39M	54.58M	66.24M	37.55M
Equity Share Income Growth			20.46%	-5.86%	-17.59%	76.42%	44.40%
Total			1.16B	1.01B	1.05B	783.71M	503.08M
Total Growth			14.59%	-3.51%	34.00%	55.78%	23.78%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Export			396.70M	441.36M	488.72M	407.79M	-
Export Growth			-10.12%	-9.69%	19.85%	-	-
China			764.48M	571.93M	561.43M	375.93M	-
China Growth			33.67%	1.87%	49.35%	-	-
Total			1.16B	1.01B	1.05B	783.71M	-
Total Growth			14.59%	-3.51%	34.00%	-	-

Source: S&P Global Market Intelligence.